Caris Life SciencesCAI
NASDAQMedical Laboratories
$16.20-1.79%
No cached AI snapshot yet for CAI.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
$5.89BMarket cap
$56.0152-week high
$16.2852-week low
2,309,704Avg volume (30d)
1,846 employees282.58M shares outstandinglisted 2025-06-18dividend yield 6.51%
Next earnings ~May 5, 2026 · Ex-dividend Sep 9, 2021 · Dividend $0.30 quarterly
About Caris Life Sciences
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Latest News
Showing market-wide stock news
Caris Life Sciences Announces Share Repurchase Program
Payrolls Reset The Fed Debate
An inflation storm is brewing in the Pacific Ocean — and your portfolio isn’t ready
New York Fed Finds Worst Financial Anxiety Since January 2023
The Need For A New Portfolio Approach
Forex Today: Markets assess Japanese GDP as ECB decision looms
Related Stocksin Medical Laboratories
Ready to see the live AI view on CAI?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing CAI side-by-side with live signals.